Continuous Glucose Monitoring – clinical trial quality data
As we have espoused here on Diabettech in the past, not all clinical trials for CGM systems are equal. To this, end, we’re now proud […]
As we have espoused here on Diabettech in the past, not all clinical trials for CGM systems are equal. To this, end, we’re now proud […]
What impact does a botched rollout of an app update have on a CGM provider?
Trying out a smartwatch with non-invasive glucose monitoring. This isnt the watch you’re looking for….
As many will have seen, the Dexcom G7 never had, and recently the G6, has removed back-smoothing from the apps on the phone, for various […]
Having tested a G7 against the Libre3, and found that without calibration, it tended to produce results that I wasn’t satisfied with using just the […]
As previously discussed in this article, I have been wearing the Libre 3, Dexcom G6 and G7, to compare performance across all three. These are […]
As I’m currently testing a Libre3, and have taken a look back at the various accuracy studies as a part of this to review MARD data, […]
It’s finally here. The Dexcom G7 has landed. And now it’s time for us here at Diabettech to pitch it against Abbott’s Freestyle Libre 3. […]
Taking a look at the reasons why Dexcom One may force Abbott to make Libre2 a true real time CGM.
London. A city of 10 million people, 32 boroughs, five Integrated care systems (ICS), and probably 66,000 people with type 1 diabetes. London. Also a […]
Copyright © 2024 | WordPress Theme by MH Themes